Chia-Ying Lin

Chia-Ying Lin

Auto-generated profile, based on publicly available information

Chia-Ying Lin

Department of Orthopaedic Surgery, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, 45267-0212, OH, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2022 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
SGStacey M.S. Gruber
Stacey M.S. Gruber
SMSumit Murab
Sumit Murab
PGPaulomi Ghosh
Paulomi Ghosh
PWPatrick W. Whitlock
Patrick W. Whitlock
CLChia-Ying J. Lin
Chia-Ying J. Lin

16 May 2018 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
RTRigwed Tatu
Rigwed Tatu
Marc OriaMarc Oria
Marc Oria
SPSarah Pulliam
Sarah Pulliam
LSLorenzo Signey
Lorenzo Signey
MRMarepalli B. Rao
Marepalli B. Rao
CLChia‐Ying Lin
Chia‐Ying Lin

10 March 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RTRigwed R. Tatu
Rigwed R. Tatu
MOMarc Oria
Marc Oria
MRMarepalli B. Rao
Marepalli B. Rao
JPJose L. Peiro
Jose L. Peiro
CLChia-Ying Lin
Chia-Ying Lin
Open spina bifida or myelomeningocele (MMC) is a devastating neurologic congenital defect characterized by primary failure of neural tube closure of the spinal column during the embryologic period. Cerebrospinal fluid leak caused by the MMC spinal defect in the developing fetus can result in a constellation of encephalic anomalies that include hindbrain herniation and hydrocephalus. The exposure of extruded spinal cord to amniotic fluid also poses a significant risk for inducing partial or complete paralysis of the body parts beneath the spinal aperture by progressive spinal cord damage in-utero. A randomized trial demonstrated that prenatal repair by fetal surgery, sometimes using patches, to cover the exposed spinal cord with a watertight barrier is effective in reducing the postnatal neurologic morbidity as evidenced by decreased incidence and severity of postnatal hydrocephalus and the reduced need for ventricular-peritoneal shunting. Currently, the use of inert or collagen-based patches are associated with high costs and inadequate structural properties. Specifically, the inert patches do not degrade after implantation, causing the need for a post-natal removal surgery associated with trauma for the newborn. Our present study is aimed towards in-vitro degradation studies of a newly designed patch, which potentially can serve as a superior alternative to existing patches for MMC repair. This novel patch was fabricated by blending poly(l-lactic acid) and poly(ε-caprolactone). The 16-week degradation study in amniotic fluid was focused on tracking changes in crystallinity and mechanical properties. An additional set of designed patches was exposed to phosphate-buffered saline (PBS), as a time-paired control. Crystallinity studies indicate the progress of hydrolytic degradation of the patch in both media, with a preference to bulk erosion in phosphate buffered saline and surface erosion in amniotic fluid. Mechanical testing results establish that patch integrity is not compromised up to 16 weeks of exposure either to body fluids analog (PBS) or to amniotic fluid.

3 February 2022 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
QXQisheng Xiong
Qisheng Xiong
NZNingze Zhang
Ningze Zhang
MZMiaomiao Zhang
Miaomiao Zhang
MWMeng Wang
Meng Wang
LWLizhen Wang
Lizhen Wang
CLChia‐Ying Lin
Chia‐Ying Lin

4 April 2022 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
MMMarcos M. Miyabe
Marcos M. Miyabe
KMKendall P. Murphy
Kendall P. Murphy
Marc OriaMarc Oria
Marc Oria
SDSoner Duru
Soner Duru
CLChia-Ying Lin
Chia-Ying Lin
JPJose L. Peiro
Jose L. Peiro

7 January 2019 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
SGStacey M. S. Gruber
Stacey M. S. Gruber
PGPaulomi Ghosh
Paulomi Ghosh
KMKarl Wilhelm Mueller
Karl Wilhelm Mueller
PWPatrick W. Whitlock
Patrick W. Whitlock
CLChia-Ying Lin
Chia-Ying Lin
3D bioprinting aims to create custom scaffolds that are biologically active and accommodate the desired size and geometry. A thermoplastic backbone can provide mechanical stability similar to native tissue while biologic agents offer compositional cues to progenitor cells, leading to their migration, proliferation, and differentiation to reconstitute the original tissues/organs1,2. Unfortunately, many 3D printing compatible, bioresorbable polymers (such as polylactic acid, PLA) are printed at temperatures of 210 °C or higher - temperatures that are detrimental to biologics. On the other hand, polycaprolactone (PCL), a different type of polyester, is a bioresorbable, 3D printable material that has a gentler printing temperature of 65 °C. Therefore, it was hypothesized that decellularized extracellular matrix (DM) contained within a thermally protective PLA barrier could be printed within PCL filament and remain in its functional conformation. In this work, osteochondral repair was the application for which the hypothesis was tested. As such, porcine cartilage was decellularized and encapsulated in polylactic acid (PLA) microspheres which were then extruded with polycaprolactone (PCL) into filament to produce 3D constructs via fused deposition modeling. The constructs with or without the microspheres (PLA-DM/PCL and PCL(-), respectively) were evaluated for differences in surface features.